✦ LIBER ✦

Assessing the costs of compliance: the Kyoto Protocol

✍ Scribed by Böhringer, Christoph ;Löschel, Andreas

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 134 KB
Volume: 12
Category: Article
ISSN: 0961-0405
DOI: 10.1002/eet.279

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Environmental policy in Europe: assessin

Environmental policy in Europe: assessing the costs of compliance

✍ Gouldson, Andy ;Williams, Evan 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 1 views

Cost of compliance assessments and the w

Cost of compliance assessments and the water industry in England and Wales

✍ McMahon, Paul 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

Assessing the costs of ‘addicted’ gamble

Assessing the costs of ‘addicted’ gamblers

✍ Dean R. Gerstein; Rachel A. Volberg; Henrick J. Harwood; Eugene M. Christiansen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Assessing Costs Against the Prescription

Assessing Costs Against the Prescription Department*

✍ Alderson, Wroe 📂 Article 📅 1932 🏛 Elsevier ⚖ 232 KB

Y2K costs & compliance: A perspective fr

Y2K costs & compliance: A perspective from the United Kingdom

✍ LuAnn Bean 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

The impact of non-compliance on the cost

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature

✍ Dyfrig A. Hughes; Adrian Bagust; Alan Haycox; Tom Walley 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract Non‐compliance with drug therapies not only limits their effectiveness, but in some instances, is associated with grave clinical sequelae and substantial economic burden. It is important, therefore, to consider non‐compliance in economic evaluations. A review of pharmacoeconomic evaluat